Jerzak, K.J.; Bouganim, N.; Brezden-Masley, C.; Edwards, S.; Gelmon, K.; Henning, J.-W.; Hilton, J.F.; Sehdev, S.
HR+/HER2– Advanced Breast Cancer Treatment in the First-Line Setting: Expert Review. Curr. Oncol. 2023, 30, 5425-5447.
https://doi.org/10.3390/curroncol30060411
AMA Style
Jerzak KJ, Bouganim N, Brezden-Masley C, Edwards S, Gelmon K, Henning J-W, Hilton JF, Sehdev S.
HR+/HER2– Advanced Breast Cancer Treatment in the First-Line Setting: Expert Review. Current Oncology. 2023; 30(6):5425-5447.
https://doi.org/10.3390/curroncol30060411
Chicago/Turabian Style
Jerzak, Katarzyna J., Nathaniel Bouganim, Christine Brezden-Masley, Scott Edwards, Karen Gelmon, Jan-Willem Henning, John F. Hilton, and Sandeep Sehdev.
2023. "HR+/HER2– Advanced Breast Cancer Treatment in the First-Line Setting: Expert Review" Current Oncology 30, no. 6: 5425-5447.
https://doi.org/10.3390/curroncol30060411
APA Style
Jerzak, K. J., Bouganim, N., Brezden-Masley, C., Edwards, S., Gelmon, K., Henning, J.-W., Hilton, J. F., & Sehdev, S.
(2023). HR+/HER2– Advanced Breast Cancer Treatment in the First-Line Setting: Expert Review. Current Oncology, 30(6), 5425-5447.
https://doi.org/10.3390/curroncol30060411